Approvals can happen at any time. Knowing they have been actively sharing data with the FDA and have a EUA submission - there mere mention of therapeutics at this meeting could generate significant interest in RLFTF. We all know the FDA has been focused on vaccines and that's probably the entire meeting BUT there is that possibility.
Best,
JB
Disclaimer
All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.
